Schroder Investment Management Group
USNA icon

Schroder Investment Management Group’s Usana Health Sciences USNA Stock Holding History

Schroder Investment Management Group’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-74,024
Closed -$5.56M – 1507
2020
Q3 		$5.56M Buy
74,024
+8,091
+12% +$649K 0.01% 708
2020
Q2 		$4.84M Buy
65,933
+64,365
+4,105% +$5.05M 0.01% 678
2020
Q1 		$110K Buy
1,568
+268
+21% +$18.6K ﹤0.01% 1178
2019
Q4 		$102K Sell
1,300
-136,100
-99% -$10M ﹤0.01% 1206
2019
Q3 		$9.51M Sell
137,400
-75,092
-35% -$5.04M 0.02% 636
2019
Q2 		$16.9M Buy
212,492
+137,430
+183% +$10.9M 0.03% 479
2019
Q1 		$6.3M Buy
75,062
+1,170
+2% +$122K 0.01% 658
2018
Q4 		$8.7K Sell
73,892
-286
-0.4% -$33.1K 0.02% 581
2018
Q3 		$8.94M Sell
74,178
-64,516
-47% -$8.01M 0.02% 619
2018
Q2 		$16M Sell
138,694
-194,364
-58% -$21.3M 0.03% 521
2018
Q1 		$28.6M Sell
333,058
-162,518
-33% -$12.6M 0.05% 378
2017
Q4 		$36.7M Sell
495,576
-17,700
-3% -$1.18M 0.06% 355
2017
Q3 		$29.6M Sell
513,276
-58,910
-10% -$3.48M 0.05% 390
2017
Q2 		$36.7M Buy
572,186
+47,448
+9% +$2.92M 0.07% 337
2017
Q1 		$30.6M Sell
524,738
-45,578
-8% -$2.72M 0.06% 375
2016
Q4 		$34.9M Sell
570,316
-16,078
-3% -$1.05M 0.07% 350
2016
Q3 		$40.6M Sell
586,394
-147,010
-20% -$9.7M 0.08% 309
2016
Q2 		$40.9M Buy
733,404
+964
+0.1% +$58.1K 0.08% 311
2016
Q1 		$43.8M Buy
732,440
+176,200
+32% +$10.4M 0.09% 273
2015
Q4 		$35.5M Buy
556,240
+373,182
+204% +$24.2M 0.07% 317
2015
Q3 		$12.3M Sell
183,058
-56,614
-24% -$4M 0.03% 562
2015
Q2 		$16.7M Sell
239,672
-456,684
-66% -$29M 0.03% 518
2015
Q1 		$38.8M Sell
696,356
-27,116
-4% -$1.39M 0.08% 316
2014
Q4 		$37.1M Sell
723,472
-1,730
-0.2% -$84.9K 0.07% 315
2014
Q3 		$26.7M Buy
725,202
+26,200
+4% +$945K 0.04% 417
2014
Q2 		$27.3M Sell
699,002
-5,000
-0.7% -$186K 0.03% 409
2014
Q1 		$26.5M Sell
704,002
-21,070
-3% -$736K 0.03% 421
2013
Q4 		$27.4M Buy
725,072
+30,200
+4% +$1.16M 0.03% 402
2013
Q3 		$30.2M Sell
694,872
-110,400
-14% -$4.43M 0.07% 326
2013
Q2 		$29.1M Buy
+805,272
New +$24.5M 0.08% 307

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schroder Investment Management Group's USNA Position: Q4 2020 in Review

Schroder Investment Management Group sold out of Usana Health Sciences (USNA) in Q4 2020, closing a stake of 74,024 shares — an estimated $5.56M sold.

Schroder Investment Management Group first reported a position in USNA in Q2 2013 and held it in 30 quarters. The position peaked at $43.8M in Q1 2016. 191 funds tracked by Wall St. Rank hold USNA as of Q4 2020.

  • Schroder Investment Management Group reported no remaining Usana Health Sciences position as of Q4 2020 after selling out during the quarter.
  • Schroder Investment Management Group sold 74,024 Usana Health Sciences shares in Q4 2020, an estimated $5.56M.
  • Schroder Investment Management Group first reported a position in Usana Health Sciences in Q2 2013 and held it in 30 quarters.
  • Schroder Investment Management Group's Usana Health Sciences position peaked at $43.8M in Q1 2016.
  • 191 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2020.

Based on Schroder Investment Management Group's 13F filing for Q4 2020, filed 16 Feb 2021.